Use of Process Modelling for Optimization of Molecular Tumor Boards

被引:2
|
作者
Lauk, Katharina [1 ]
Peters, Mia-Carlotta [2 ]
Velthaus, Janna-Lisa [2 ]
Nurnberg, Sylvia [1 ]
Ueckert, Frank [1 ]
机构
[1] Univ Hosp Hamburg Eppendorf UKE, Inst Appl Med Informat, D-20251 Hamburg, Germany
[2] Hubertus Wald Univ, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Comprehens Canc Ctr Hamburg,Univ Med Ctr Hamburg, D-20251 Hamburg, Germany
来源
APPLIED SCIENCES-BASEL | 2022年 / 12卷 / 07期
关键词
Molecular Tumor Board (MTB); BPMN; 2; 0; Business Process Modeling; Service-Oriented Architecture; personalized medicine; personalized oncology; precision oncology; molecular oncology; SERVICE-ORIENTED ARCHITECTURE; IMPACT;
D O I
10.3390/app12073485
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In Molecular Tumor Boards, a team of experts discuss the individual therapy options of a cancer patient based on their individual molecular profile. The process-from recommendation request, through molecular diagnosis, to a personalized therapy recommendation-is complex and time-consuming. Therefore, process optimization is needed to decrease the workload of physicians and to standardize the process. For this purpose, we modeled the current workflow of the Molecular Tumor Board at the University Hospital Hamburg-Eppendorf on Service-Oriented Architecture using Business Process Modeling and Notation to highlight areas for improvement. This identified many manual tasks and an extensive workload for the physician. We then created a novel, simplified, more efficient workflow in which the physician is supported by additional software. In summary, we show that the use of Service-Oriented Architecture using Business Process Modeling and Notation for Molecular Tumor Board processes promotes rapid adaptability, standardization, interoperability, quality assurance, and facilitates collaboration.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Molecular Tumor Boards
    Rody, Achim
    Ettl, Johannes
    Marme, Frederik
    Prat, Aleix
    [J]. BREAST CARE, 2018, 13 (02) : 141 - 143
  • [2] Implementation of an automated interoperable order entry process for virtual molecular tumor boards
    Sigle, S.
    Werner, P.
    Fegeler, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 215 - 215
  • [3] The use of hybrid modelling for the optimization of the penicillin fermentation process
    Preusting, H
    Noordover, J
    Simutis, R
    Lubbert, A
    [J]. CHIMIA, 1996, 50 (09) : 416 - 417
  • [4] Molecular tumor boards - insights and perspectives
    Lassmann, Silke
    Hummel, Michael
    [J]. PATHOLOGE, 2021, 42 (04): : 357 - 362
  • [5] Precision oncology and molecular tumor boards
    Mack, Elisabeth
    Horak, Peter
    Froehling, Stefan
    Neubauer, Andreas
    [J]. INNERE MEDIZIN, 2024, 65 (05): : 462 - 471
  • [6] Molecular Tumor Boards: On the evolution of species
    Giacomini, Patrizio
    Ciliberto, Gennaro
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 201
  • [7] Clinical bioinformatics desiderata for molecular tumor boards
    Pallocca, Matteo
    Betti, Martina
    Baldinelli, Sara
    Palombo, Ramona
    Bucci, Gabriele
    Mazzarella, Luca
    Tonon, Giovanni
    Ciliberto, Gennaro
    [J]. BRIEFINGS IN BIOINFORMATICS, 2024, 25 (05)
  • [8] Clinical Outcomes of Molecular Tumor Boards: A Systematic Review
    Larson, Kara L.
    Huang, Bin
    Weiss, Heidi L.
    Hull, Pam
    Westgate, Philip M.
    Miller, Rachel W.
    Arnold, Susanne M.
    Kolesar, Jill M.
    [J]. JCO PRECISION ONCOLOGY, 2021, 5 : 1122 - 1132
  • [9] A comparison of treatment recommendations by molecular tumor boards worldwide
    Rieke, D. T.
    Leyvraz, S.
    Burock, S.
    Keilholz, U.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Bridging the Biomarker Chasm With Interprofessional Molecular Tumor Boards
    Kolesar, Jill M.
    Arnold, Susanne M.
    Ueland, Frederick R.
    Evers, B. Mark
    [J]. JCO ONCOLOGY PRACTICE, 2023, 19 (08) : 677 - +